Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

UBE2I anticorps (AA 1-157)

UBE2I Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7170967
  • Antigène Voir toutes UBE2I Anticorps
    UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
    Épitope
    • 7
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 1-157
    Reactivité
    • 71
    • 35
    • 34
    • 7
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 57
    • 13
    • 2
    Lapin
    Clonalité
    • 47
    • 25
    Polyclonal
    Conjugué
    • 37
    • 6
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    Cet anticorp UBE2I est non-conjugé
    Application
    • 48
    • 25
    • 22
    • 10
    • 8
    • 8
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human SUMO-conjugating enzyme UBC9 protein (1-157AA)
    Isotype
    IgG
    Top Product
    Discover our top product UBE2I Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
    Autre désignation
    UBE2I (UBE2I Produits)
    Synonymes
    anticorps C358B7.1, anticorps P18, anticorps UBC9, anticorps ubc9, anticorps ube2ia, anticorps zUbc9, anticorps 5830467E05Rik, anticorps F830028O17Rik, anticorps Ubce2i, anticorps Ubce9, anticorps UbcE2A, anticorps ubce9, anticorps T13J8.70, anticorps T13J8_70, anticorps UBIQUITIN-PROTEIN LIGASE, anticorps ubiquitin conjugating enzyme 9, anticorps ubiquitin conjugating enzyme E2 I, anticorps ubiquitin-conjugating enzyme E2Ib, anticorps ubiquitin-conjugating enzyme E2L, anticorps ubiquitin-conjugating enzyme E2I, anticorps ubiquitin conjugating enzyme E2I S homeolog, anticorps ubiquitin conjugating enzyme 9, anticorps SUMO-conjugating enzyme UBC9, anticorps UBE2I, anticorps ube2ib, anticorps UBE2L, anticorps Ube2i, anticorps ube2i.S, anticorps UBC9, anticorps ubc-9, anticorps LOC108703134
    Sujet

    Background: Accepts the ubiquitin-like proteins SUMO1, SUMO2, SUMO3 and SUMO4 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2 or CBX4. Necessary for sumoylation of FOXL2 and KAT5. Essential for nuclear architecture and chromosome segregation

    Aliases: C358B7.1 antibody, p18 antibody, SUMO 1 protein ligase antibody, SUMO conjugating enzyme UBC9 antibody, SUMO-conjugating enzyme UBC9 antibody, SUMO-protein ligase antibody, SUMO1 protein ligase antibody, UBC9 antibody, UBC9_HUMAN antibody, UBCE9 antibody, Ube2i antibody, Ubiquitin carrier protein 9 antibody, Ubiquitin carrier protein antibody, Ubiquitin carrier protein I antibody, Ubiquitin conjugating enzyme 9 antibody, Ubiquitin conjugating enzyme E2I (homologous to yeast UBC9) antibody, Ubiquitin conjugating enzyme E2I (UBC9 homolog, yeast) antibody, Ubiquitin conjugating enzyme UbcE2A antibody, Ubiquitin like protein SUMO 1 conjugating enzyme antibody, Ubiquitin protein ligase E2I antibody, Ubiquitin-conjugating enzyme E2 I antibody, Ubiquitin-protein ligase I antibody

    UniProt
    P63279
    Pathways
    Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Ubiquitin Proteasome Pathway
Vous êtes ici: